NDAORALTABLET, EXTENDED RELEASE
Approved
Jun 1965
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Clinical Trials (5)
INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)
Started Aug 2025
Assessment of Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban, or Aspirin Plus REGN9933, or Aspirin Plus REGN7508 in Healthy Adult Participants
Started Sep 2024
224 enrolled
Healthy Volunteers
Assess Gastrointestinal Blood Loss After Receiving Aspirin or Aspirin Plus Rivaroxaban in Healthy Adult Participants
Started Jan 2023
60 enrolled
Healthy Volunteer
A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants
Started Mar 2022
58 enrolled
Coronary Artery DiseaseHealthy Participants
Using Aspirin to Improve Immunological Features of Ovarian Tumors
Started Nov 2021
100 enrolled
Ovarian CancerFallopian Tube CancerPeritoneal Cancer